News Chart MegaPro Biomedical Co., Ltd

Equities

6827

TW0006827009

End-of-day quote Taipei Exchange Other stock markets 18:00:00 2024-06-13 EDT			5-day change	1st Jan Change
23 ^TWD	+1.77%		+2.22%	-5.54%

2022	Megapro Biomedical Co., Ltd Successfully Completes the Biological Evaluations of Iop as Vaccine Adjuvant T Cell Mediated Immunity Is Substantially Enhanced, Improving the Efficacy of Vaccines	CI
2022	Megapro Biomedical Co., Ltd, China Chemical & Pharmaceutical Co., Ltd. and Wellbridge Biotech Ltd. Jointly Establishes an Inhalation Dosage Form Company	CI

59de2cfabda4c2.DaQff1TL2IhnzJcqof3eTndxh1fjxkfU-07KHLYCLs0.TsVxBjG7tc4q-edY6qKBGERC_w2QqTSNtS-Oc_VQaq9I4287Ir2H7D771g~02f5ce09c6f09ef4d294417d2d4c796e